{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NS2b-NS3 protease", "computer-aided drug design", "dengue virus", "molecular modeling", "phytochemicals"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39057092", "DateRevised": {"Year": "2024", "Month": "07", "Day": "28"}, "Article": {"Language": ["eng"], "ELocationID": ["10.3390/cimb46070451"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "18"}], "Journal": {"ISSN": "1467-3045", "JournalIssue": {"Volume": "46", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "18"}}, "Title": "Current issues in molecular biology", "ISOAbbreviation": "Curr Issues Mol Biol"}, "ArticleTitle": "Using Multiscale Molecular Modeling to Analyze Possible NS2b-NS3 Protease Inhibitors from Philippine Medicinal Plants.", "Pagination": {"StartPage": "7592", "EndPage": "7618", "MedlinePgn": "7592-7618"}, "Abstract": {"AbstractText": ["Within the field of Philippine folkloric medicine, the utilization of indigenous plants like <i>Euphorbia hirta</i> (<i>tawa-tawa</i>), <i>Carica papaya</i> (<i>papaya</i>), and <i>Psidium guajava</i> (<i>guava</i>) as potential dengue remedies has gained attention. Yet, limited research exists on their comprehensive effects, particularly their anti-dengue activity. This study screened 2944 phytochemicals from various Philippine plants for anti-dengue activity. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling provided 1265 compounds demonstrating pharmacokinetic profiles suitable for human use. Molecular docking targeting the dengue virus NS2b-NS3 protease's catalytic triad (Asp 75, Ser 135, and His 51) identified ten ligands with higher docking scores than reference compounds idelalisib and nintedanib. Molecular dynamics simulations confirmed the stability of eight of these ligand-protease complexes. Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) analysis highlighted six ligands, including veramiline (-80.682 kJ/mol), cyclobranol (-70.943 kJ/mol), chlorogenin (-63.279 kJ/mol), 25beta-Hydroxyverazine (-61.951 kJ/mol), etiolin (-59.923 kJ/mol), and ecliptalbine (-56.932 kJ/mol) with favorable binding energies, high oral bioavailability, and drug-like properties. This integration of traditional medical knowledge with advanced computational drug discovery methods paves new pathways for the development of treatments for dengue."]}, "AuthorList": [{"Identifier": ["0009-0009-2419-8860"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, University of the Philippines Diliman, Quezon City 1101, Philippines."}], "LastName": "Cordero", "ForeName": "Allen Mathew Fortuno", "Initials": "AMF"}, {"Identifier": ["0000-0002-0551-8664"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, University of the Philippines Diliman, Quezon City 1101, Philippines."}], "LastName": "Gonzales", "ForeName": "Arthur A", "Initials": "AA", "Suffix": "3rd"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Curr Issues Mol Biol", "NlmUniqueID": "100931761", "ISSNLinking": "1467-3037"}, "CoiStatement": "After a thorough review of the manuscript in accordance with the established criteria for financial and non-financial competing interests, the authors declare that there are no competing interests to report. Regarding financial competing interests, the authors confirm that none of them have received reimbursements, fees, funding, or salaries from any organization that may be financially impacted by the publication of this manuscript, presently or in the future. They do not own any stocks or shares, nor are they holding or applying for any patents related to the manuscript\u2019s content. There has also been no financial support or association with organizations holding or applying for patents relevant to the manuscript. Concerning non-financial competing interests, the authors state that there are no political, personal, religious, ideological, academic, or intellectual interests that might be viewed as conflicting with the content or publication of this manuscript."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Amir-Hassan A., Lee V.S., Baharuddin A., Othman S., Xu Y., Huang M., Yusof R., Rahman N.A., Othman R. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein. J. Mol. Graph. Model. 2017;74:273\u2013287. doi: 10.1016/j.jmgm.2017.03.010.", "ArticleIdList": ["10.1016/j.jmgm.2017.03.010", "28458006"]}, {"Citation": "Villanueva R. Philippines Logs 220,705 Dengue Cases in 2022. The Philippine Star. Jan 17, 2023.  [(accessed on 20 March 2023)].  Available online:  https://www.philstar.com/nation/2023/01/17/2238093/philippines-logs-220705-dengue-cases-2022."}, {"Citation": "Aguiar M., Stollenwerk N. Dengvaxia: Age as surrogate for serostatus. Lancet Infect. Dis. 2018;18:245. doi: 10.1016/S1473-3099(17)30752-1.", "ArticleIdList": ["10.1016/S1473-3099(17)30752-1", "29276049"]}, {"Citation": "Padmapriya P., Fathima S.G., Ramanathan G., Yuvaraj V., Kaveri K., Gunasekaran P., Sivagnanam U.T., Thennarasu S. Development of antiviral inhibitor against dengue 2 targeting Ns3 protein: In vitro and in silico significant studies. Acta Trop. 2018;188:1\u20138. doi: 10.1016/j.actatropica.2018.08.022.", "ArticleIdList": ["10.1016/j.actatropica.2018.08.022", "30145258"]}, {"Citation": "Uday R.V.S., Misra R., Harika A., Dolui S., Saha A., Pal U., Ravichandiran V., Maiti N.C. Dabrafenib, idelalisib and nintedanib act as significant allosteric modulator for dengue NS3 protease. PLoS ONE. 2021;16:e0257206. doi: 10.1371/journal.pone.0257206.", "ArticleIdList": ["10.1371/journal.pone.0257206", "PMC8432871", "34506566"]}, {"Citation": "Abduraman M.A., Hariono M., Yusof R., Rahman N.A., Wahab H.A., Tan M.L. Development of a NS2B/NS3 protease inhibition assay using AlphaScreen\u00ae beads for screening of anti-dengue activities. Heliyon. 2018;4:e01023. doi: 10.1016/j.heliyon.2018.e01023.", "ArticleIdList": ["10.1016/j.heliyon.2018.e01023", "PMC6289942", "30560214"]}, {"Citation": "Erbel P., Schiering N., D\u2019Arcy A., Renatus M., Kroemer M., Lim S.P., Yin Z., Keller T.H., Vasudevan S.G., Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 2006;13:372. doi: 10.1038/nsmb1073.", "ArticleIdList": ["10.1038/nsmb1073", "16532006"]}, {"Citation": "Da Silva-J\u00fanior E.F., De Ara\u00fajo-J\u00fanior J.X. Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses. Bioorg. Med. Chem. 2019;27:3963\u20133978. doi: 10.1016/j.bmc.2019.07.038.", "ArticleIdList": ["10.1016/j.bmc.2019.07.038", "31351847"]}, {"Citation": "Perera S.D., Jayawardena U.A., Jayasinghe C.D. Potential Use of Euphorbia hirta for Dengue: A Systematic Review of Scientific Evidence. J. Trop. Med. 2018;2018:2048530. doi: 10.1155/2018/2048530.", "ArticleIdList": ["10.1155/2018/2048530", "PMC5926475", "29849664"]}, {"Citation": "Yildiz M., Ghosh S., Bell J.A., Sherman W., Hardy J.A. Allosteric Inhibition of the NS2B-NS3 Protease from Dengue Virus. ACS Chem. Biol. 2013;8:2744\u20132752. doi: 10.1021/cb400612h.", "ArticleIdList": ["10.1021/cb400612h", "PMC3923078", "24164286"]}, {"Citation": "Hanwell M.D., Curtis D.E., Lonie D.C., Vandermeersch T., Zurek E., Hutchison G.R. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 2012;4:17. doi: 10.1186/1758-2946-4-17.", "ArticleIdList": ["10.1186/1758-2946-4-17", "PMC3542060", "22889332"]}, {"Citation": "Schr\u00f6dinger . Schr\u00f6dinger Release 2019-3. Maestro, Schr\u00f6dinger LLC; New York, NY, USA: 2019."}, {"Citation": "\u0160ali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993;234:779\u2013815. doi: 10.1006/jmbi.1993.1626.", "ArticleIdList": ["10.1006/jmbi.1993.1626", "8254673"]}, {"Citation": "Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 1997;18:2714\u20132723. doi: 10.1002/elps.1150181505.", "ArticleIdList": ["10.1002/elps.1150181505", "9504803"]}, {"Citation": "Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B.A., Thiessen P.A., Yu B., et al. PubChem 2023 update. Nucleic Acids Res. 2023;51:D1373\u2013D1380. doi: 10.1093/nar/gkac956.", "ArticleIdList": ["10.1093/nar/gkac956", "PMC9825602", "36305812"]}, {"Citation": "Tung C.-W. Public databases of plant natural products for computational drug discovery. Curr. Comput.-Aided Drug Des. 2014;10:191\u2013196. doi: 10.2174/1573409910666140414145934.", "ArticleIdList": ["10.2174/1573409910666140414145934", "24724941"]}, {"Citation": "Macalalad M.A.B., Gonzales A.A., III In Silico Screening and Identification of Antidiabetic Inhibitors Sourced from Phytochemicals of Philippine Plants against Four Protein Targets of Diabetes (PTP1B, DPP-4, SGLT-2, and FBPase) Molecules. 2023;28:5301. doi: 10.3390/molecules28145301.", "ArticleIdList": ["10.3390/molecules28145301", "PMC10384415", "37513175"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Athanasiadis E., Cournia Z., Spyrou G. ChemBioServer: A web-based pipeline for filtering, clustering and visualization of chemical compounds used in drug discovery. Bioinformatics. 2012;28:3002\u20133003. doi: 10.1093/bioinformatics/bts551.", "ArticleIdList": ["10.1093/bioinformatics/bts551", "22962344"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsq. Adv. Drug Deliv. Rev. 2001;46:3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "Ghose A.K., Viswanadhan V.N., Wendoloski J.J. A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases. J. Comb. Chem. 1999;1:55\u201368. doi: 10.1021/cc9800071.", "ArticleIdList": ["10.1021/cc9800071", "10746014"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.-Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "Egan W.J., Merz K.M., Baldwin J.J. Prediction of Drug Absorption Using Multivariate Statistics. J. Med. Chem. 2000;43:3867\u20133877. doi: 10.1021/jm000292e.", "ArticleIdList": ["10.1021/jm000292e", "11052792"]}, {"Citation": "Muegge I., Heald S.L., Brittelli D. Simple Selection Criteria for Drug-like Chemical Matter. J. Med. Chem. 2001;44:1841\u20131846. doi: 10.1021/jm015507e.", "ArticleIdList": ["10.1021/jm015507e", "11384230"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Shamsian S., Sokouti B., Dastmalchi S. Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries. Bioimpacts. 2023;14:29955. doi: 10.34172/bi.2023.29955.", "ArticleIdList": ["10.34172/bi.2023.29955", "PMC10945300", "38505677"]}, {"Citation": "De Sousa L.R.F., Wu H., Nebo L., Fernandes J.B., Da Silva M.F.D.G.F., Kiefer W., Kanitz M., Bodem J., Diederich W.E., Schirmeister T., et al. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies. Bioorg. Med. Chem. 2015;23:466\u2013470. doi: 10.1016/j.bmc.2014.12.015.", "ArticleIdList": ["10.1016/j.bmc.2014.12.015", "25564380"]}, {"Citation": "Lemkul J. From Proteins to Perturbed Hamiltonians: A Suite of Tutorials for the GROMACS-2018 Molecular Simulation Package [Article v1.0] LiveCoMS. 2018;1:5068. doi: 10.33011/livecoms.1.1.5068.", "ArticleIdList": ["10.33011/livecoms.1.1.5068"]}, {"Citation": "Vanommeslaeghe K., Hatcher E., Acharya C., Kundu S., Zhong S., Shim J., Darian E., Guvench O., Lopes P., Vorobyov I., et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 2009;31:671\u2013690. doi: 10.1002/jcc.21367.", "ArticleIdList": ["10.1002/jcc.21367", "PMC2888302", "19575467"]}, {"Citation": "Homeyer N., Gohlke H. Free Energy Calculations by the Molecular Mechanics Poisson\u2212Boltzmann Surface Area Method. Mol. Inf. 2012;31:114\u2013122. doi: 10.1002/minf.201100135.", "ArticleIdList": ["10.1002/minf.201100135", "27476956"]}, {"Citation": "Kumari R., Kumar R., Open Source Drug Discovery Consortium. Lynn A. g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations. J. Chem. Inf. Model. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Veeresham C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Tech. Res. 2012;3:200. doi: 10.4103/2231-4040.104709.", "ArticleIdList": ["10.4103/2231-4040.104709", "PMC3560124", "23378939"]}, {"Citation": "Ononamadu C., Ibrahim A. Molecular docking and prediction of ADME/drug-likeness properties of potentially active antidiabetic compounds isolated from aqueous-methanol extracts of Gymnema sylvestre and Combretum micranthum. BioTechnologia. 2021;102:85\u201399. doi: 10.5114/bta.2021.103765.", "ArticleIdList": ["10.5114/bta.2021.103765", "PMC9645566", "36605715"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera\u2014A Visualization System for Exploratory Research and Analysis. J. Comput. Chem. 2004;25:1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Zhao H., Caflisch A. Molecular dynamics in drug design. Eur. J. Med. Chem. 2015;91:4\u201314. doi: 10.1016/j.ejmech.2014.08.004.", "ArticleIdList": ["10.1016/j.ejmech.2014.08.004", "25108504"]}, {"Citation": "Siqueira A.S., Lima A.R.J., de Souza R.C., Santos A.S., Vianez J.L., da S.G., Gon\u00e7alves E.C. Anti-dengue virus activity of scytovirin and evaluation of point mutation effects by molecular dynamics and binding free energy calculations. Biochem. Biophys. Res. Commun. 2017;490:1033\u20131038. doi: 10.1016/j.bbrc.2017.06.160.", "ArticleIdList": ["10.1016/j.bbrc.2017.06.160", "28666874"]}, {"Citation": "Chagas C.M., Moss S., Alisaraie L. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski\u2019s Rule of Five. Int. J. Pharm. 2018;549:133\u2013149. doi: 10.1016/j.ijpharm.2018.07.046.", "ArticleIdList": ["10.1016/j.ijpharm.2018.07.046", "30040971"]}, {"Citation": "Aqil F., Munagala R., Jeyabalan J., Vadhanam M.V. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013;334:133\u2013141. doi: 10.1016/j.canlet.2013.02.032.", "ArticleIdList": ["10.1016/j.canlet.2013.02.032", "PMC3815990", "23435377"]}, {"Citation": "Ferreira De Freitas R., Schapira M. A systematic analysis of atomic protein\u2013ligand interactions in the PDB. Med. Chem. Commun. 2017;8:1970\u20131981. doi: 10.1039/C7MD00381A.", "ArticleIdList": ["10.1039/C7MD00381A", "PMC5708362", "29308120"]}, {"Citation": "Nittinger E., Inhester T., Bietz S., Meyder A., Schomburg K.T., Lange G., Klein R., Rarey M. Large-Scale Analysis of Hydrogen Bond Interaction Patterns in Protein\u2013Ligand Interfaces. J. Med. Chem. 2017;60:4245\u20134257. doi: 10.1021/acs.jmedchem.7b00101.", "ArticleIdList": ["10.1021/acs.jmedchem.7b00101", "28497966"]}, {"Citation": "Aguilera-Pesantes D., Robayo L.E., M\u00e9ndez P.E., Mollocana D., Marrero-Ponce Y., Torres F.J., M\u00e9ndez M.A. Discovering key residues of dengue virus NS2b-NS3-protease: New binding sites for antiviral inhibitors design. Biochem. Biophys. Res. Commun. 2017;492:631\u2013642. doi: 10.1016/j.bbrc.2017.03.107.", "ArticleIdList": ["10.1016/j.bbrc.2017.03.107", "28343993"]}, {"Citation": "Rothan H.A., Han H.C., Ramasamy T.S., Othman S., Rahman N.A., Yusof R. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis. 2012;12:314. doi: 10.1186/1471-2334-12-314.", "ArticleIdList": ["10.1186/1471-2334-12-314", "PMC3575220", "23171075"]}, {"Citation": "Chen J., Jiang H., Li F., Hu B., Wang Y., Wang M., Wang J., Cheng M. Computational insight into dengue virus NS2B-NS3 protease inhibition: A combined ligand-and structure-based approach. Comput. Biol. Chem. 2018;77:261\u2013271. doi: 10.1016/j.compbiolchem.2018.09.010.", "ArticleIdList": ["10.1016/j.compbiolchem.2018.09.010", "30393100"]}, {"Citation": "Ritchie T.J., Macdonald S.J.F. Physicochemical Descriptors of Aromatic Character and Their Use in Drug Discovery: Miniperspective. J. Med. Chem. 2014;57:7206\u20137215. doi: 10.1021/jm500515d.", "ArticleIdList": ["10.1021/jm500515d", "24856517"]}, {"Citation": "Becker O., Mackerell A.D., Jr., Roux B., Watanabe M. Computational Biochemistry and Biophysics. CRC Press; Boca Raton, FL, USA: 2001. Comparative Protein Structure Modelling; p. 275."}, {"Citation": "Yuan S., Chan H.C.S., Hu Z. Using PyMOL as a platform for computational drug design. WIREs Comput. Mol. Sci. 2017;7:e1298. doi: 10.1002/wcms.1298.", "ArticleIdList": ["10.1002/wcms.1298"]}]}], "History": [{"Year": "2024", "Month": "6", "Day": "5"}, {"Year": "2024", "Month": "7", "Day": "15"}, {"Year": "2024", "Month": "7", "Day": "16"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "12", "Minute": "48"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "12", "Minute": "47"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "8", "Minute": "36"}, {"Year": "2024", "Month": "7", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["39057092", "PMC11275823", "10.3390/cimb46070451", "cimb46070451"]}}]}